Revolutionize the way we prevent, detect, and respond to major 21st century health security threats.

Endotyping for Host-Directed Therapeutics is now open for abstract submissions

Apply Now

BARDA Mask Innovation Challenge Phase 2

This challenge aims to support the development of innovative masks that can protection Americans from respiratory pathogens, such as SARS-CoV-2, and other airborne hazards.

See Challenge Details
masks

EZ-BAA now open for COVID-19 medical countermeasures Abstract Submissions

Apply Now
Blue Molecules

ReDIRECT is now open for abstract submissions.

Apply Now

BARDA DRIVe Launches First Venture Capital Partnership

BARDA DRIVe Launches First Venture Capital Partnership to Develop Transformative Technologies to Combat Future Pandemics, Other Health Emergencies

#HealthSecurity #SaveLives

Read More

Pediatric COVID-19 Data Challenge

You can help develop computational models to predict children at risk for severe COVID-19 complications

See Challenge Details

Next Generation Sequencing-based Agnostic Diagnostic

For more information

Mitigating Long-term Effects (MILE) of Respiratory Distress is now open for abstract submissions

Apply Now

2021 Federal Wearables Summit Recordings Now Available

Learn from innovators, care providers, researchers, data security specialists, regulators, insurers, and more about the future of wearable sensors for monitoring health and health quality.

Watch the Presentations
wearables_summit

BARDA Evolves ENACT Into Two New Programs

EZ-BAA is now open

CURRENT PROGRAMS

Our individual DRIVe programs accelerate the development and availability of transformative technologies and approaches to protect Americans from health security threats. We push the boundaries of innovation to tackle the biggest health security challenges.

ENACT

Provide health information to individuals at early stages of infection, injury, or illness.

Read More
ImmuneChip+

Enhance the usability of 3D human tissue models (“tissue chips”) as tools for drug development.

Read More
COVID-19 Response

Use pathogen-agnostic technologies from the ENACT and Solving Sepsis portfolios in response to COVID-19.

Read More
Beyond The Needle

Develop alternative delivery methods for vaccines and other therapeutics.

Read More
ReDIRECT

Repurpose commonly available therapeutics to treat symptoms associated with chemical agent exposure.

Read More
Solving Sepsis

Seek interventions to identify sepsis early resulting in improved patient outcomes and decreased mortality.

Read More
Digital Health Tools for Pandemic Preparedness

First line of defense against health threats with rapidly deployable digital tools​​.

Read More
Bringing Laboratory Testing to the Home

Enabling better health outcomes through biological sample testing at the point-of-care.

Read More
Covid-19 At Home Diagnostics

Home-based, over the counter diagnostics and enabling technologies for the detection of SARS CoV-2.

Read More


UPCOMING DRIVe EVENTS

Find out more about DRIVe upcoming events


Click for List of Past Events



DRIVe's Impact

  • We change how government approaches big health security challenges and threats

  • We tackle health security threats by seeking breakthrough devices and technologies

  • We model our work on the best practices of the entrepreneurial world.

  • We use tools and authorities to support new technologies, streamline contracting processes, and launch a network of accelerators

  • The team is comprised of scientists and venture entrepreneurs dedicated to identifying threats to health security


Investing Process